Getting to Grip with Non-Invasive Tests to Assess Liver Fibrosis & Patient Eligibility for Novel MASH Therapies
Nov 10 2025
Convention Center: Room 150, Level 1
12:30 PM
- 2:00 PM
Description
Join us for a symposium on liver fibrosis designed to encourage the exchange of ideas between leaders in the field and attendees.
Supported by: Siemens Healthineers
Organized by: Medscape Education
For more information and to register, visit: https://events.medscapelive.org/website/89041/
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.
Have increased knowledge regarding the: Cut-off values for use of noninvasive tests to assess liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Clinical data on novel therapies for MASH.
Have greater competence related to evaluating liver fibrosis in patients with MASH
Demonstrate greater confidence in their ability to assess for liver fibrosis using noninvasive tests